Company Filing History:
Years Active: 1998-2002
Title: Barbara Waters: Innovator in Eukaryotic Protein Kinase Inhibition
Introduction
Barbara Waters is a notable inventor based in Delta, California. She has made significant contributions to the field of biochemistry, particularly in the area of eukaryotic protein kinases. With a total of 5 patents to her name, her work has implications for various biological and medical applications.
Latest Patents
Among her latest patents is a method for inhibiting eukaryotic protein kinases using lichen-derived organic acids such as vulpinic acid and usnic acid. These compounds have been found to effectively inhibit eukaryotic protein kinase activity in samples or organisms. Another significant patent involves the discovery that lipopeptide biosurfactants, such as surfactin and viscosin, can also inhibit eukaryotic protein kinase activity. This method includes adding an effective inhibitory amount of these biosurfactants to the sample or organism.
Career Highlights
Barbara has worked with companies such as Terragen Diversity, Inc. and Terragen Discovery Inc. Her innovative approaches have led to advancements in understanding and manipulating protein kinase activity, which is crucial for various cellular processes.
Collaborations
Throughout her career, Barbara has collaborated with esteemed colleagues, including Julian E. Davies and Geeta Saxena. These partnerships have enriched her research and contributed to her success as an inventor.
Conclusion
Barbara Waters stands out as a pioneering inventor in the field of eukaryotic protein kinase inhibition. Her contributions continue to influence research and applications in biochemistry and related fields.